Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Alzheimer's disease development candidate related to donepezil identified at Eisai

April 10, 2001

Secretin reported to produce significant clinical response in autism

April 10, 2001

Synaptic on track to file IND for lead antidepressant drug candidate

April 10, 2001

Epimmune and Elan establish licensing agreement for PADRE technology

April 10, 2001

Inhibitors of NO production claimed for MS, RA, CHF and dilated cardiomyopathy

April 9, 2001

New serotonergic compounds described as particularly useful for depression, memory disorders

April 9, 2001

Axonyx's phenserine regulates APP processing in preclinical study

April 9, 2001

Efficacy and lack of CNS adverse effects reported for Adolor analgesic

April 9, 2001

DuPont describes efforts to design improved antipsychotic agents

April 9, 2001

Selective sigma2 receptor ligands patented by Santen

April 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....